This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rotimi, C. Articles by Morrison Ryk Ward, L. Search for Related Content PubMed PubMed Citation Articles by Rotimi, C. Articles by Morrison Ryk Ward, L.

(Hypertension. 1996;27:558-563.)
© 1996 American Heart Association, Inc.

Articles

Polymorphisms of Renin-Angiotensin Genes Among Nigerians, Jamaicans, and African Americans

Charles Rotimi; Angel Puras; Richard Cooper; Norma McFarlane-Anderson; Terrence Forrester; Olufemi Ogunbiyi; Linda Morrison Ryk Ward

From the Department of Preventive Medicine and Epidemiology, Loyola University Stritch School of Medicine, Maywood, Ill (C.R., A.P., R.C.); the Tropical Metabolism Research Unit, University of the West Indies, Mona, Jamaica (N.M.-A., T.F.); University College Hospital, Ibadan, Nigeria (O.O.); and the Department of Human Genetics, University of Utah, Salt Lake City (L.M., R.W.).

Abstract Within the context of an international collaborative study of the evolution of hypertension in the black diaspora, we determined the allelic distribution of hypertension candidate genes for the renin-angiotensin system in three populations of African origin. The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) and the M235T and T174M variants of the angiotensinogen (AGT) gene were examined in individuals from Nigeria, Jamaica, and the United States. Large differences in the prevalence of hypertension were recorded in door-to-door surveys, ranging from 16% in Nigeria to 33% in the United States. The frequency of the D allele was similar in all groups (54%, 59%, and 63% in Nigeria, Jamaica, and the United States, respectively). The 235T allele of the AGT gene was found in 81% of US and Jamaican blacks and 91% of Nigerians; very little variation was seen for the T174M marker. Despite large differences in hypertension rates, genetic variation at the index loci among these groups was modest. Overall, the frequency of the ACE^*D allele was only slightly higher than that reported for European and Japanese populations, whereas the AGT 235T allele was twice as common. Compared with blacks in the western hemisphere, Nigerians had a higher frequency of the 235T allele, which is consistent with 25% European admixture in Jamaica and the United States. The results indicate the potential for etiologic heterogeneity in genetic factors related to hypertension across ethnic groups while suggesting that environmental exposures most likely explain the gradient in risk in the comparison among black populations.

Key Words: angiotensinogen • angiotensin-converting enzyme • genetics • hypertension, genetic • blacks

This article has been cited by other articles:

				L. D. Jenkins, R. W. Powers, M. Cooper, M. J. Gallaher, N. Markovic, R. Ferrell, R. B. Ness, and J. M. Roberts Preeclampsia Risk and Angiotensinogen Polymorphisms M235T and AGT -217 in African American and Caucasian Women Reproductive Sciences, September 1, 2008; 15(7): 696 - 701. [Abstract] [PDF]

				I. Goldenberg, A. J. Moss, D. Ryan, S. McNitt, S. W. Eberly, and W. Zareba Polymorphism in the Angiotensinogen Gene, Hypertension, and Ethnic Differences in the Risk of Recurrent Coronary Events Hypertension, October 1, 2006; 48(4): 693 - 699. [Abstract] [Full Text] [PDF]

				I. J. Benjamin, D. K. Arnett, and J. Loscalzo Discovering the Full Spectrum of Cardiovascular Disease: Minority Health Summit 2003: Report of the Basic Science Writing Group Circulation, March 15, 2005; 111(10): e120 - e123. [Full Text] [PDF]

				A. Bouzamondo, J.-S. Hulot, P. Sanchez, and P. Lechat Beta-blocker benefit according to severity of heart failure Eur J Heart Fail, June 1, 2003; 5(3): 281 - 289. [Abstract] [Full Text] [PDF]

				B. R. Palmer, A. P. Pilbrow, T. G. Yandle, C. M. Frampton, A. M. Richards, M. G. Nicholls, and V. A. Cameron Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction J. Am. Coll. Cardiol., March 5, 2003; 41(5): 729 - 736. [Abstract] [Full Text] [PDF]

				D. A. Price, N. D.L. Fisher, M. C. Lansang, R. Stevanovic, G. H. Williams, and N. K. Hollenberg Renal Perfusion in Blacks: Alterations Caused by Insuppressibility of Intrarenal Renin With Salt Hypertension, August 1, 2002; 40(2): 186 - 189. [Abstract] [Full Text] [PDF]

				The Beta-Blocker Evaluation of Survival Trial Inve A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure N. Engl. J. Med., May 31, 2001; 344(22): 1659 - 1667. [Abstract] [Full Text] [PDF]

				L. Gleiberman and J. E. Dimsdale Salt, Hypertension, Evolution Response Psychosom Med, March 1, 2001; 63(2): 325 - 327. [Full Text] [PDF]

				J. V. Gainer, C. M. Stein, T. Neal, D. E. Vaughan, and N. J. Brown Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular Reactivity Hypertension, January 1, 2001; 37(1): 46 - 51. [Abstract] [Full Text] [PDF]

				A. Okamura, M. Ohishi, H. Rakugi, T. Katsuya, Y. Yanagitani, S. Takiuchi, Y. Taniyama, K. Moriguchi, H. Ito, Y. Higashino, et al. Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty Angiology, October 1, 1999; 50(10): 811 - 822. [Abstract] [PDF]

				C. N. Rotimi, R. S. Cooper, G. Cao, O. Ogunbiyi, M. Ladipo, E. Owoaje, and R. Ward Maximum-Likelihood Generalized Heritability Estimate for Blood Pressure in Nigerian Families Hypertension, March 1, 1999; 33(3): 874 - 878. [Abstract] [Full Text] [PDF]

				M. J. MALIARIK, B. A. RYBICKI, E. MALVITZ, R. G. SHEFFER, M. MAJOR, J. POPOVICH Jr., and M. C. IANNUZZI Angiotensin-converting Enzyme Gene Polymorphism and Risk of Sarcoidosis Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1566 - 1570. [Abstract] [Full Text] [PDF]

				T. Ishigami, S. Umemura, K. Tamura, K. Hibi, N. Nyui, M. Kihara, M. Yabana, Y. Watanabe, Y. Sumida, T. Nagahara, et al. Essential Hypertension and 5' Upstream Core Promoter Region of Human Angiotensinogen Gene Hypertension, December 1, 1997; 30(6): 1325 - 1330. [Abstract] [Full Text]

				R. Kunz, R. Kreutz, J. Beige, A. Distler, and A. M. Sharma Association Between the Angiotensinogen 235T-Variant and Essential Hypertension in Whites : A Systematic Review and Methodological Appraisal Hypertension, December 1, 1997; 30(6): 1331 - 1337. [Abstract] [Full Text]

				C. Rotimi, R. Cooper, O. Ogunbiyi, L. Morrison, M. Ladipo, D. Tewksbury, and R. Ward Hypertension, Serum Angiotensinogen, and Molecular Variants of the Angiotensinogen Gene Among Nigerians Circulation, May 20, 1997; 95(10): 2348 - 2350. [Abstract] [Full Text]